.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Deloitte
Boehringer Ingelheim
Mallinckrodt
UBS
Federal Trade Commission
Novartis
Healthtrust
AstraZeneca

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,747,150

« Back to Dashboard

Summary for Patent: 6,747,150

Title: Boronic ester and acid compounds, synthesis and uses
Abstract:Disclosed herein is a method for reducing the rate of degradation of proteins in an animal comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
Inventor(s): Adams; Julian (Brookline, MA), Ma; Yu-Ting (Lexington, MA), Stein; Ross (Sudbury, MA), Baevsky; Matthew (Boston, MA), Grenier; Louis (Medford, MA), Plamondon; Louis (Watertown, MA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:10/392,165
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

International Patent Family for Patent: 6,747,150

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria241631► Subscribe
Austria314378► Subscribe
Austria411324► Subscribe
Australia4139896► Subscribe
Australia710564► Subscribe
Canada2203936► Subscribe
Canada2496538► Subscribe
Switzerland0788360► Subscribe
Chile2004001150► Subscribe
China101077875► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
Teva
US Department of Justice
Harvard Business School
Queensland Health
US Army
Covington
Chubb
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot